Expert opinions on the diagnostic criteria, disease activity measures and treatment recommendations in patients with AOSD are shared. The role IL-1 inhibitors in achieving sustained disease remission and tapering the use of corticosteroids in patients with AOSD is also presented.
Total length of recording approx. 40 min: Presenters and disclosures at 2:00 mins, lectures at 4:00 mins, Q...Läs mer
SE2309226001 (22 September 2023)